Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Gibson

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|September 5, 2002
EditorialMartin Gibson
BMC Medical Research Methodology|October 24, 2019
Can a 'consent to contact' community help research teams overcome barriers to recruitment? The development and impact of the 'Research for the Future' communityKatherine Grady, Martin Gibson, Peter Bower
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|September 11, 2024
[The loneliness barometer 2024: methodology and selected results]Janosch Schobin, Martin Gibson-Kunze, Céline Arriagada
The American Journal of Cardiology|October 9, 2007
Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined C-reactive protein (<2 mg/L) and low-density lipoprotein cholesterol (< 70 mg/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA study)D John Betteridge, J Martin Gibson, Philip T Sager
Cardiovascular Endocrinology & Metabolism|November 12, 2021
The risk factors potentially influencing risk of serious illness/death in people with diabetes, following SARS-CoV-2 infection: What needs to be done from hereAdrian H Heald, Mark Livingston, Gabriela Moreno, et al.
International Journal of Clinical Practice|May 12, 2020
COVID-19: Generate and apply local modelled transmission and morbidity effects to provide an estimate of the variation in overall relative healthcare resource impact at general practice granularityMike Stedman, Mark Lunt, Mark Davies, et al.
The Journal of Biological Chemistry|July 13, 2004
Abrogation of insulin-like growth factor-I (IGF-I) and insulin action by mevalonic acid depletion: synergy between protein prenylation and receptor glycosylation pathwaysKirk W Siddals, Emma Marshman, Melissa Westwood, et al.
Diabetes Care|December 24, 2004
Specialist nurse-led clinics to improve control of hypertension and hyperlipidemia in diabetes: economic analysis of the SPLINT trialJames M Mason, Nick Freemantle, J Martin Gibson, et al.
Cardiovascular Endocrinology & Metabolism|January 9, 2023
Type 2 diabetes and mortality in females versus males in England: the Salford diabetes cohortAdrian H Heald, Mike Stedman, Ian Laing, et al.
Health Policy (Amsterdam, Netherlands)|September 19, 2025
Employment models for general practitioners in england: evidence from repeated surveysJonathan Martin Gibson, Sean Urwin, Sharon Spooner, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Diabetic Medicine : a Journal of the British Diabetic Association|September 5, 2002
EditorialMartin Gibson
BMC Medical Research Methodology|October 24, 2019
Can a 'consent to contact' community help research teams overcome barriers to recruitment? The development and impact of the 'Research for the Future' communityKatherine Grady, Martin Gibson, Peter Bower
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|September 11, 2024
[The loneliness barometer 2024: methodology and selected results]Janosch Schobin, Martin Gibson-Kunze, Céline Arriagada
The American Journal of Cardiology|October 9, 2007
Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined C-reactive protein (<2 mg/L) and low-density lipoprotein cholesterol (< 70 mg/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA study)D John Betteridge, J Martin Gibson, Philip T Sager
Cardiovascular Endocrinology & Metabolism|November 12, 2021
The risk factors potentially influencing risk of serious illness/death in people with diabetes, following SARS-CoV-2 infection: What needs to be done from hereAdrian H Heald, Mark Livingston, Gabriela Moreno, et al.
International Journal of Clinical Practice|May 12, 2020
COVID-19: Generate and apply local modelled transmission and morbidity effects to provide an estimate of the variation in overall relative healthcare resource impact at general practice granularityMike Stedman, Mark Lunt, Mark Davies, et al.
The Journal of Biological Chemistry|July 13, 2004
Abrogation of insulin-like growth factor-I (IGF-I) and insulin action by mevalonic acid depletion: synergy between protein prenylation and receptor glycosylation pathwaysKirk W Siddals, Emma Marshman, Melissa Westwood, et al.
Diabetes Care|December 24, 2004
Specialist nurse-led clinics to improve control of hypertension and hyperlipidemia in diabetes: economic analysis of the SPLINT trialJames M Mason, Nick Freemantle, J Martin Gibson, et al.
Cardiovascular Endocrinology & Metabolism|January 9, 2023
Type 2 diabetes and mortality in females versus males in England: the Salford diabetes cohortAdrian H Heald, Mike Stedman, Ian Laing, et al.
Health Policy (Amsterdam, Netherlands)|September 19, 2025
Employment models for general practitioners in england: evidence from repeated surveysJonathan Martin Gibson, Sean Urwin, Sharon Spooner, et al.
Pageof 10